Impact of pulsatile perfusion on postoperative outcome of kidneys from controlled donors after cardiac death

Transplant International

Volumn 21, Issue 9, 2008, Pages 899-907

  Plata Munoz, Juan J ^a   Muthusamy, Anand ^a   Quiroga, Isabel ^a   Contractor, Harold H ^a   Sinha, Sanjay ^a   Vaidya, Anil ^a   Darby, Christopher ^a   Fuggle, Susan V ^a   Friend, Peter J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiac death; Controlled donors; Kidney transplant; Preservation; Pulsatile perfusion

Indexed keywords

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DELAYED GRAFT FUNCTION; FEMALE; GRAFT SURVIVAL; HEART DEATH; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY PERFUSION; LENGTH OF STAY; MALE; ORGAN DONOR; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL; TISSUE PRESERVATION;

ADOLESCENT; ADULT; DELAYED GRAFT FUNCTION; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN PRESERVATION; PERFUSION; PULSATILE FLOW;

EID: 49649101853     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00685.x     Document Type: Article

References (56)

1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant. N Engl J Med 1999 341 : 1725.
2. Daemen JHC, Oomen APA, Kelders WPA, et al. The potential pool of non-heart-beating kidney donors. Clin Transplant 1997 11 : 149.
3. Sanchez-Fructuoso AI, Prats D, Torrente J, et al. Renal transplantation from non-heart-beating donors: a promising alternative to enlarge the donor pool. J Am Soc Nephrol 2000 11 : 350.
4. Lacroix JD, Mahoney JE, Knoll GA. Renal transplantation using non-heart-beating donors: a potential solution to the organ donor shortage in Canada. Can J Surg 2004 47 : 10.
5. Gagandeep S, Matsouka L, Mateo R, et al. Expanding the donor kidney pool: utility of renal allografts procured in a setting of uncontrolled cardiac death. Am J Transplant 2006 6 : 1682.
6. Doshi MD, Hunsicker LG. Short and long-term outcomes with the use of kidneys and livers donated after cardiac death. Am J Transplant 2007 7 : 122.
7. Kokkinos C, Antcliffe D, Nanidis T, Darzi AW, Tekkis P, Papalois V. Outcome of kidney transplantation from non-heart-beating versus heart-beating cadaveric donors. Transplantation 2007 83 : 1193.
8. Tojimbara T, Fuchinoue S, Iwadoh K, et al. Improved outcomes of renal transplantation from cardiac death donors: a 30 years single center experience. Am J Transplant 2007 7 : 1.
9. Locke JE, Segev DL, Warren DS, et al. Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation. Am J Transplant 2007 7 : 1797.
10. Chapman J, Bock A, Dussol B, et al. Follow-up after renal transplantation with organs from donors after cardiac death. Transpl Int 2006 19 : 715.
11. Butterworth PC, Taub N, Doughman TM, et al. Are kidneys from non-heart-beating donors second class organs? Transplant Proc 1997 29 : 3567.
12. Vanrenterghem Y. Cautious approach to use of non-heart-beating donors. Lancet 2000 356 : 528.
13. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997 63 : 968.
14. McLaren AJ, Jassem W, Gray DW, Fuggle SV, Welsh KI, Morris PJ. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 1999 13 : 266.
15. Quiroga I, McShane P, Koo DD, et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006 21 : 1689.
16. Matas AJ, Gillingham KJ, Elick BA, et al. Risk factors for prolonged hospitalization after kidney transplants. Clin Transplant 1997 11 : 259.
17. Hagenmeyer EG, Häussler B, Hempel E, et al. Resource use and treatment costs after kidney transplantation: impact of demographic factors, comorbidities, and complications. Transplantation 2004 77 : 1545.
18. Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc 1995 27 : 2893.
19. Koostra G, Kievit J, Nederstigt A. Organ donors: heart-beating and non-heart-beating. World J Surg 2002 26 : 181.
20. Rohr MS. Renal allograft acute tubular necrosis. A light and electron microscopic study of biopsies taken at procurement and after revascularization. Ann Surg 1983 197 : 663.
21. Olsen S, Burdick JF, Keown P, Wallace AC, Racusen L, Solez K. Primary acute renal failure (acute tubular necrosis) in the transplanted kidney: morphology and pathogenesis. Medicine 1989 68 : 173.
22. Sudhindran S, Pettigrew GJ, Drain A, et al. Outcomes of transplantation using kidneys from controlled (Masstrich category 3) non-heart-beating donors. Clin Transplant 2003 17 : 93.
23. Lange H, Kulhman U. Organ procurement policy: should we reduce cold ischemia times? Transplant Proc, 1998 30 : 4297.
24. Offermann G. What is a reasonably short cold ischemia time in kidney transplantation. Transplant Proc 1998 30 : 4291.
25. Hauet T, Goujon JM, Vandewalle A. To what extend can limiting cold ischaemia/reperfusion injury prevent delayed graft function? Nephrol Dial Transplant 2001 16 : 1982.
26. Carter JT, Chan S, Roberts JP, Sandy F. Expanded criteria donor kidney allocation: marked decrease in cold ischaemia and delayed graft function at a single center. Am J Transplant 2005 5 : 2745.
27. Stratta RJ, Moore PS, Farney AC, et al. Influence of pulsatile perfusion on outcomes in kidney transplantation from expanded criteria donors. J Am Coll Surg 2007 204 : 873.
28. Moustafellos P, Hadjianastassiou V, Roy D, et al. The influence of pulsatile preservation in kidney transplantation from Non-heart-beating donors. Transplant Proc 2007 39 : 1323.
29. Matsuoka L, Shah T, Aswad S, et al. Pulsatile perfusion reduces the incidence of delayed graft function in expanded criteria donor kidney transplantation. Am J Transplant 2006 6 : 1473.
30. Schold JD, Kaplan B, Howard RJ, Reed AI, Foley DP, Meier-Kriesche HU. Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation. Am J Transplant 2005 5 : 1681.
31. Nyberg S, Baskin-Bey ES, Kremers W, Prieto M, Henry ML, Stegall MD. Improving the prediction fo donor kidney quality: deceased donor score and resistive indices. Transplantation 2005 80 : 925.
32. Wight J, Chilcott J, Holmes M, Brewer N. The clinical and cost effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors. Health Technol Assess 2003 7 : 1.
33. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713.
34. Russell JD, Beecroft ML, Ludwin D. Churchill DN: the quality of life in renal transplantation: a prospective study. Transplantation 1992 54 : 656.
35. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996 50 : 235.
36. Transplant Activity in the UK. UK Transplant website, http://www.uktransplant.org.uk/ukt/statistics/transplant_activity_report/ current_activity_reports/ukt/transplant_activity_uk_2005-2006_v2.pdf (accessed 8 August 2007).
37. Department of Health. Organs for transplants: a report from the organ donation task force 2008. Available at: http://www.dh.gov.uk (accessed 1 April 2008).
38. Brook NR, Waller JR, Nicholson ML. Non-heart-beating kidney donation. Current practice and future developments. Kidney Int 2003 63 : 1516.
39. Pessione F, Cohen S, Durand D, et al. Multivariate analysis of donor risk factor for graft survival in kidney transplantation. Transplantation 2003 75 : 361.
40. Siddiqi N, McBride MA, Hariran S. Similar risk profiles of post-transplant renal dysfunction and long-term graf failure: UNOS/OPTN database analysis. Kidney Int 2004 65 : 1906.
41. He X, Johnston A. Risk factors for allograft failure in United Kingdom renal transplant recipients treated with cyclosporine A. Transplantation 2005 79 : 953.
42. Asher J, Wilson OC, Gupta A, et al. A simple cardiovascular risk score can predict poor outcome in NHBD renal transplantation. Transplant Proc 2005 37 : 3292.
43. Jamieson NV, Sundberg R, Lindell S, et al. Preservation of the canine liver for 24-48 h using simple cold storage with UW solution. Transplantation 1988 46 : 517.
44. Jamieson NV, Lindell S, Sundberg R, Southard JH, Belzer FO. An analysis of the components in UW solution using the isolated perfused rabbit liver. Transplantation 1988 46 : 512.
45. Contractor HH, Johnson PR, Chadwick DR, Robertson GS, London NJ. The effect of UW solution and its components on the collagenase digestion of human and porcine pancreas. Cell Transplant 1995 4 : 615.
46. Muhlbacher F, Langer F, Mittermayer C. Preservation solutions for transplantation. Transplant Proc 1999 31 : 2069.
47. British Transplantation Society. BTS Submission for the National Institute for Health and Clinical Excellence Health Technology (NICE) Appraisal of Kidney Preservation, 2008. http://www.uktransplant.org.uk (accessed on 1 March 2008).
48. Ambiru S, Uryuhara K, Talpe S, et al. Improved survival of orthotopic liver allograft in swine by addition of trophic factors to University of Wisconsin solution. Transplantation 2004 77 : 302.
49. McAnulty JF, Reid TW, Waller KR, Murphy CJ. Successful six-day kidney preservation using trophic factor supplemented media and simple cold storage. Am J Transplant 2002 2 : 712.
50. Koike N, Takeyoshi I, Ohki S, Tokumine M, Matsumoto K, Morishita Y. Effects of adding P38 mitogen-activated protein-kinase inhibitor to celsior solution in canine heart transplantation from non-heart-beating donors. Transplantation 2004 77 : 286.
51. Yoshinari D, Takeyoshi I, Kobayashi M, et al. Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to university of wisconsin solution on reperfusion injury in liver transplantation. Transplantation 2001 72 : 22.
52. Tan HP, Smaldone MC, Shapiro R. Immunosupressive preconditioning or induction regimens. Evidence to date. Drugs 2006 66 : 1535.
53. Brennan D, Daller JA, Lake KD, et al. Rabbit antithymocite globuline versus basiliximab in renal transplantation. N Engl J Med 2006 355 : 19.
54. Mourad G, Rostaing L, Legendre C, et al. Sequential protocols using basiliximab versus antithymocyte globulins in renal transplant patients receiving mycophenolate mofetil and steroids. Transplantation 2004 78 : 584.
55. Shapiro R, Basu A, Tan H, et al. Kidney transplantation under minimal immunosuppression after pre-transplant lymphoid depletion with thymoglobulin or campath. J Am Coll Surg 2005 200 : 505.
56. Axelrod DA, Guidinger MK, McCullough KP, Leichtman AB, Punch JD, Merion RM. Association of center volume with outcome after liver and kidney transplantation. Am J Transplant 2004 4 : 920.